|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.82 EUR | +1.34% |
|
+0.17% | -7.24% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 75.38 | +29.85% | 9 | ||||||
| 1,215.79 | +4.72% | 29 | ||||||
| 252.87 | +6.1% | 23 | ||||||
| 253.55 | +12.8% | 29 | ||||||
| 360.76 | +10.9% | 17 | ||||||
| 220.95 | +21.97% | 21 | ||||||
| 154.88 | +1.93% | 21 | ||||||
| 311.78 | +10.34% | 23 | ||||||
| 352.5 | -0.44% | 30 | ||||||
| 157.83 | +25.39% | 29 | ||||||
| 29.19 | +11.53% | 27 | ||||||
| 63.08 | +10.86% | 25 | ||||||
| 548.69 | +23.29% | 29 | ||||||
| 96.92 | +27.03% | 23 | ||||||
| 20.77 | +5.82% | 19 | ||||||
| 9,973.33 | +34.27% | 15 | ||||||
| 6,136.87 | +21.93% | 15 | ||||||
| 81.26 | +72.98% | 16 | ||||||
| 49.47 | +38.23% | 19 | ||||||
| 4.175 | +24.99% | 17 | ||||||
| Average | 1,018 | +19.72% | 22 | ||||||
| Weighted average by Cap. | 710.18 | +11.32% | 25 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
